Subarachnoid Hemorrhage Surgical Devices companies

  • Report ID: 3333
  • Published Date: Sep 30, 2025
  • Report Format: PDF, PPT

Key Subarachnoid Hemorrhage Surgical Devices Market Players:

    The subarachnoid hemorrhage surgical devices are primarily focused on large med-tech conglomerates, such as Medtronic, Stryker, and Johnson & Johnson. These legacy players are increasingly incorporating advanced imaging, AI-assisted navigation, and microcatheters. Mid-sized firms in Europe enter into niche positions with innovative devices. While several entry-level companies are pushing the limits in AI-assisted navigation. Partnerships spanning imaging and interventional technologies are enhancing regulatory approval paths and expanding competitive landscapes in this active sector.

    Below is the list of some prominent players operating in the global market:

    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Stryker Corporation
    • Johnson & Johnson (Cerenovus)
    • MicroPort Scientific Corporation
    • Penumbra, Inc.
    • Terumo Corporation
    • Balt Extrusion (Wallaby Medical)
    • Acandis GmbH
    • Integra LifeSciences
    • B. Braun Melsungen AG
    • Cook Medical
    • Kaneka Medix Corporation
    • Lepu Medical Technology
    • MicroVention, Inc. (Terumo)
    • Rapid Medical
    • Phenox GmbH
    • SMT (Sahajanand Medical Technologies)
    • Cardiatis
    • Gynesonics
    • Boston Scientific Corporation

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2026, the industry size of subarachnoid hemorrhage surgical devices is estimated at USD 1.6 billion.

Subarachnoid hemorrhage surgical devices market size was valued at USD 1.5 billion in 2025 and is projected to reach USD 2.9 billion by the end of 2035, rising at a CAGR of 5.3% during the forecast period, i.e., 2026-2035.

North america is expected to dominate the global subarachnoid hemorrhage surgical devices market with the largest share of 40.7% by the end of 2035.

The major players in the market are Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), MicroPort Scientific Corporation, Penumbra, Inc., Terumo Corporation, Balt Extrusion (Wallaby Medical), Acandis GmbH, Integra LifeSciences, B. Braun Melsungen AG, Cook Medical, Kaneka Medix Corporation, Lepu Medical Technology, MicroVention, Inc. (Terumo), Rapid Medical, Phenox GmbH, SMT (Sahajanand Medical Technologies), Cardiatis, Gynesonics, Boston Scientific Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos